BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26307263)

  • 21. Electrospun diclofenac sodium loaded Eudragit® L 100-55 nanofibers for colon-targeted drug delivery.
    Shen X; Yu D; Zhu L; Branford-White C; White K; Chatterton NP
    Int J Pharm; 2011 Apr; 408(1-2):200-7. PubMed ID: 21291969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implication of nanofibers in oral drug delivery.
    Kapahi H; Khan NM; Bhardwaj A; Mishra N
    Curr Pharm Des; 2015; 21(15):2021-36. PubMed ID: 25732659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "Missing Tooth" Multidomain Peptide Nanofibers for Delivery of Small Molecule Drugs.
    Li IC; Moore AN; Hartgerink JD
    Biomacromolecules; 2016 Jun; 17(6):2087-95. PubMed ID: 27253735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interplay of membrane formation and drug release in solution-cast films of polylactide polymers.
    Ma D; McHugh AJ
    Int J Pharm; 2010 Mar; 388(1-2):1-12. PubMed ID: 20025948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development, optimization and evaluation of polymeric electrospun nanofiber: A tool for local delivery of fluconazole for management of vaginal candidiasis.
    Sharma R; Garg T; Goyal AK; Rath G
    Artif Cells Nanomed Biotechnol; 2016; 44(2):524-31. PubMed ID: 25315503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drugs Loaded into Electrospun Polymeric Nanofibers for Delivery.
    Torres-Martinez EJ; Pérez-González GL; Serrano-Medina A; Grande D; Vera-Graziano R; Cornejo-Bravo JM; Villarreal-Gómez LJ
    J Pharm Pharm Sci; 2019; 22(1):313-331. PubMed ID: 31329535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time-engineeringed biphasic drug release by electrospun nanofiber meshes.
    Huang LY; Branford-White C; Shen XX; Yu DG; Zhu LM
    Int J Pharm; 2012 Oct; 436(1-2):88-96. PubMed ID: 22789913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellulose nanofibers as excipient for the delivery of poorly soluble drugs.
    Löbmann K; Svagan AJ
    Int J Pharm; 2017 Nov; 533(1):285-297. PubMed ID: 28951349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and evaluation of accelerated drug release testing methods for a matrix-type intravaginal ring.
    Externbrink A; Eggenreich K; Eder S; Mohr S; Nickisch K; Klein S
    Eur J Pharm Biopharm; 2017 Jan; 110():1-12. PubMed ID: 27793758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alternating current electrospinning for preparation of fibrous drug delivery systems.
    Balogh A; Cselkó R; Démuth B; Verreck G; Mensch J; Marosi G; Nagy ZK
    Int J Pharm; 2015 Nov; 495(1):75-80. PubMed ID: 26320549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanofibers as novel drug carrier--An overview.
    Morie A; Garg T; Goyal AK; Rath G
    Artif Cells Nanomed Biotechnol; 2016; 44(1):135-43. PubMed ID: 25016918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo wound healing performance of drug loaded electrospun composite nanofibers transdermal patch.
    Kataria K; Gupta A; Rath G; Mathur RB; Dhakate SR
    Int J Pharm; 2014 Jul; 469(1):102-10. PubMed ID: 24751731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrospun tri-layered zein/PVP-GO/zein nanofiber mats for providing biphasic drug release profiles.
    Lee H; Xu G; Kharaghani D; Nishino M; Song KH; Lee JS; Kim IS
    Int J Pharm; 2017 Oct; 531(1):101-107. PubMed ID: 28830784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fast dissolving paracetamol/caffeine nanofibers prepared by electrospinning.
    Illangakoon UE; Gill H; Shearman GC; Parhizkar M; Mahalingam S; Chatterton NP; Williams GR
    Int J Pharm; 2014 Dec; 477(1-2):369-79. PubMed ID: 25455779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spray-dried nanofibrillar cellulose microparticles for sustained drug release.
    Kolakovic R; Laaksonen T; Peltonen L; Laukkanen A; Hirvonen J
    Int J Pharm; 2012 Jul; 430(1-2):47-55. PubMed ID: 22465549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of polymer-based electrospun nanofibers containing amorphous drug dispersions for the delivery of poorly water-soluble pharmaceuticals.
    Brewster ME; Verreck G; Chun I; Rosenblatt J; Mensch J; Van Dijck A; Noppe M; Ariën A; Bruining M; Peeters J
    Pharmazie; 2004 May; 59(5):387-91. PubMed ID: 15212307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrospun nanofiber-based niflumic acid capsules with superior physicochemical properties.
    Radacsi N; Giapis KP; Ovari G; Szabó-Révész P; Ambrus R
    J Pharm Biomed Anal; 2019 Mar; 166():371-378. PubMed ID: 30711806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melt dispersion granules: formulation and evaluation to improve oral delivery of poorly soluble drugs - a case study with valsartan.
    Chella N; Tadikonda R
    Drug Dev Ind Pharm; 2015 Jun; 41(6):888-97. PubMed ID: 24796274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and pharmaceutical evaluation of nano-fiber matrix supported drug delivery system using the solvent-based electrospinning method.
    Hamori M; Yoshimatsu S; Hukuchi Y; Shimizu Y; Fukushima K; Sugioka N; Nishimura A; Shibata N
    Int J Pharm; 2014 Apr; 464(1-2):243-51. PubMed ID: 24440839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrospun shikonin-loaded PCL/PTMC composite fiber mats with potential biomedical applications.
    Han J; Chen TX; Branford-White CJ; Zhu LM
    Int J Pharm; 2009 Dec; 382(1-2):215-21. PubMed ID: 19660536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.